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Edited by Vladimir SkulachevAbstract Gulonolactone treatment of mice resulted in the
elevation of hepatic ascorbate and hydrogen peroxide levels
accompanied by transient liver swelling and reversible dilatation
of endoplasmic reticulum cisternae. Although a decrease in
glutathione (reduced form)/total glutathione ratio was observed
in microsomes, the redox state of luminal foldases remained
unchanged and the signs of endoplasmic reticulum stress were
absent. Increased permeability of the microsomal membrane to
various compounds of low molecular weight was substantiated.
It is assumed that Gulonolactone-dependent luminal hydrogen
peroxide formation in the endoplasmic reticulum provokes a tem-
porary increase in non-selective membrane permeability, which
results in the dilation of the organelle and in enhanced transmem-
brane ﬂuxes of small molecules.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Oxidative folding of secretory and membrane proteins is a
major pathway in the endoplasmic reticulum (ER) of profes-
sional secretory cells [1]. The process, executed by an electron
relay system composed by oxidoreductases, allows oxidation
of cysteine residues in nascent polypeptide chains to form
intramolecular disulﬁde bonds in the lumen of the ER [2,3].
Oxygen appears to be the ﬁnal oxidant in aerobic living organ-
isms, although the existence of alternative electron acceptorsAbbreviations: ER, endoplasmic reticulum; ERO1, endoplasmic retic-
ulum oxidoreductin 1; GLO, gulonolactone oxidase; GSH, glutathione
(reduced form); IP3R, inositol 1,4,5-trisphosphate receptor; ROS,
reactive oxygen species
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(ERO1), the ultimate component of the electron transfer chain
catalyzes the incomplete reduction of oxygen; therefore protein
oxidation in the ER is connected to generation of reactive oxy-
gen species (ROS), presumably hydrogen peroxide [4]. In fact,
reduction of molecular oxygen by recombinant yeast Ero1p
yields stoichiometric hydrogen peroxide production under aer-
obic conditions [5].
Since ROS generated during oxidative protein folding can
compromise the redox and antioxidant homeostasis of ER
lumen, it has been postulated as a causative factor of ER stress
in conditions characterized by the overproduction of secretory
proteins [6]. However, elevation of luminal hydrogen peroxide
(or ROS) levels has not been proved under these conditions.
Furthermore, the antioxidant defense of the ER lumen seems
more vulnerable than that of the other subcellular compart-
ments, e.g. there are no reports of catalase or superoxide dismu-
tase isoforms being present (for a review, see [7]). The question
remains how secretory cells with heavy loads of protein thiols in
the luminal compartment of the ER can accommodate to or
eliminate the byproducts of disulﬁde bond formation.
To model the situation in excessive oxidative folding, we took
advantage of the presence of another hydrogen peroxide gener-
ating enzyme in the ER lumen. Gulonolactone oxidase (GLO)
catalyses the last step of ascorbate synthesis with generation of
hydrogen peroxide as a byproduct [8]. Gulonolactone easily
crosses both the plasma and ERmembranes and reaches the ac-
tive site of the enzyme. Addition of gulonolactone results in an
increase of ascorbate production in isolated murine hepato-
cytes. At the same time, a decrease in reduced glutathione
(GSH) level was observed [9]. In hepatic microsomal vesicles,
ascorbate synthesis stimulated by gulonolactone causes an al-
most equimolar consumption of added GSH [9]. In glutathi-
one-loaded microsomes, gulonolactone addition results in the
preferential oxidation of intraluminal glutathione demonstrat-
ing the intraluminal formation of hydrogen peroxide [10].
In this study, the eﬀect of gulonolactone was investigated
in vivo in mice and in vitro in hepatic microsomal vesicles.
The results show that gulonolactone-dependent intraluminal
hydrogen peroxide formation in the ER provokes a temporary
increase in the non-selective membrane permeability, which re-
sults in ER dilation and in enhanced transmembrane ﬂuxes of
small molecules including glutathione. The mechanism can beblished by Elsevier B.V. All rights reserved.
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accumulation of ROS in the ER and the exhaustion of the
antioxidant capacity of the lumen.2. Materials and methods
2.1. Animal experiments
Male CD-1 mice (20–25 g body weight) and male Hartley guinea
pigs (250–300 g body weight) were purchased from Charles River Hun-
gary (Isaszeg). Animal treatments were approved by the Committee on
Animal Experiments of Semmelweis University, Budapest. Animals
were kept with ad libitum access to food and water. Gulonolactone
was dissolved in physiological saline and was injected intraperitoneally
in a volume of 1 ml. Control animals received an equivalent volume of
the vehicle. At various time points after treatment (0.5 or 24 h) animals
were sacriﬁced. Liver samples were taken and processed for electron
microscopy. The remnant of the liver was homogenized in sucrose–
HEPES buﬀer (0.3 M sucrose, 0.02 M HEPES, pH 7.2) with a glass-
Teﬂon homogenizer. The microsomal fraction was then isolated using
fractional centrifugation as detailed elsewhere [11]. Microsomes were
immediately frozen in liquid nitrogen, and kept in liquid nitrogen until
use. The integrity of the microsomal membranes was assessed by using
the mannose-6-phosphatase assay [12] and by measuring p-nitrophenol
glucuronidation [13], which showed latency greater than 95%.
2.2. Electron microscopy
For transmission electron microscopy investigation, upon dissection
after an in vivo treatment, the liver samples were immediately ﬁxed in
0.5% glutaraldehyde + 2% paraformaldehyde (PolySciences Europe
GmbH., Eppelheim, Germany) in 0.1 M cacodylate buﬀer (pH 7.2)
containing 0.25 M sucrose and 2 mM CaCl2 for 2 h at room tempera-
ture, postﬁxed in 1% osmium tetroxide (Serva Feinbiochemica
GmbH., Heidelberg, Germany) in 0.1 M cacodylate buﬀer, dehydrated
in ascending series of ethanols, inﬁltrated in propylene oxide, and
embedded in Durcupan ACM resin (Fluka AG, Buchs, Switzerland).
Ultrathin sections were contrasted with uranyl acetate and lead citrate
and electron micrographs were taken by a Jeol JEM100 CX II electron
microscope operating at 60 kV.
2.3. Immunoblotting
The protein concentration of samples was measured using the Bio-
Rad ‘‘microprotein assay kit’’. Equal amounts of microsomal proteins
(25 lg) were separated in 9% SDS–PAGE and transferred to PVDF
ﬁlter membranes by electroblotting. The ﬁlter membranes were
incubated overnight with the primary antibodies (dilution 1:1000;
anti-procaspase-12 and anti-eIF2a from Cell Signaling Technology,
anti-ERp72 from Calbiochem, all other from Santa Cruz Biotechnol-
ogy), and for 1 h with the species-speciﬁc peroxidase-conjugated
secondary antibodies (dilution 1:2000; anti-goat, anti-mouse and
anti-rabbit IgGs from Santa Cruz Biotechnology, anti-rat IgG from
Sigma). The antibodies were detected using a chemiluminescence
reagent (ECL) kit (Amersham) and blue-sensitive X-ray ﬁlm. Equal
protein loading was also veriﬁed by Ponceau-staining of the membrane
and by b-actin detection. Band intensities were quantiﬁed by densitom-
etry using ImageQuant software.
The thiol redox state of ER foldases was investigated by alkylation
with 4-acetamido-4 0-maleimidylstilbene-2,2 0-disulfonic acid (AMS;
Molecular Probes) as reported in [14]. For the reduced and oxidized
controls, microsomal samples corresponding to 0.04 g protein were
incubated at 37 C for 15 min with 0.05 M dithiothreitol or with
0.025 M diamide, respectively.
2.4. Transport measurements by rapid ﬁltration
Microsomal suspensions were diluted to 15 mg of protein/ml, in a
cytosol-like solution containing 100 mM KCl, 20 mM NaCl, 1 mM
MgCl2, 20 mMMops, pH 7.2 (KCl–Mops buﬀer). Microsomal vesicles
were pre-equilibrated with 1 mM sucrose plus [U14C]sucrose (15–
16 lCi/ml). The microsomal suspensions were then 100-fold diluted
in the KCl–Mops buﬀer at 22 C to activate the eﬄux. At the indicated
time points, 0.4 ml samples were taken and rapidly ﬁltered on a cellu-
lose acetate/nitrate membrane (pore size 0.22 lm) under gentle suction.
Filters were washed with 3 ml of ice-cold 0.25 M sucrose buﬀered withKCl–Mops, containing 1 mM 4,40-diisothiocyanatostilbene-2,2 0-disul-
fonic acid. Just before diluting, 4 ll of the microsomal suspensions
were withdrawn, rapidly mixed with 0.4 ml of the washing medium
(see above), and ﬁltered to determine the zero’’ time amounts of the
investigated compound associated to microsomes. The radioactivity
associated with microsomes retained by ﬁlters was measured by liquid
scintillation counting.
For the measurement of GSH uptake, microsomal vesicles (1 mg of
protein/ml) were incubated at room temperature (22 C) in KCl–Mops
buﬀer containing 1 mM GSH and its radiolabelled analogue [3H]GSH
(10 lCi/ml). At the indicated times, aliquots (0.1 ml) were withdrawn,
ﬁltered and washed quickly on the ﬁlter with the same ice-cold buﬀer.
The radioactivity retained on the ﬁlter was measured by liquid
scintillation. Alamethicin (50 lg/mg of protein) was included in
parallel incubates to distinguish the intravesicular and the bound
radioactivities. The alamethicin-treated vesicles were recovered on
ﬁlters and washed as above. The alamethicin-releasable portion of
radioactivity (regarded as intravesicular) was calculated by subtrac-
tion.
2.5. Transport measurements by light scattering technique
The permeability of the microsomal membranes to various com-
pounds was measured by the continuous detection of the osmotically
induced changes in size and shape of microsomal vesicles [15].
2.6. Measurement of enzyme activities
UDP-glucuronosyltransferase and mannose-6-phosphatase activities
were measured in KCl–Mops buﬀer containing 1 mg/ml microsomal
protein and 2 mM UDP-glucuronic acid plus 0.5 mM p-nitrophenol
or 5 mM mannose-6-phosphate at 37 C. p-Nitrophenol disappearance
[13] or phosphate production [15] was measured. Alamethicin
(50 lg/mg of protein) was included in parallel incubates to permeabi-
lize the vesicles for the determination of total activities.
2.7. Metabolite measurements
Determination of glutathione content of liver or microsomes were
performed by HPLC analysis as described in [16]. Glutathione
measurement from freezed–thawed microsomes gives a good approxi-
mation of the original ER glutathione levels because permeation of
both GSH and GSSG through microsomal membranes is relatively
slow [17,18].
Hydrogen peroxide content of liver homogenates was measured by
Amplex Red Assay Kit (Invitrogen, Carlsbad, CA) according to
the manufacturers instruction. The protein concentration in homoge-
nates and microsomal samples was determined using the Bio-Rad
microprotein assay kit (Hercules, CA, USA) according to the manufac-
turers instructions with bovine serum albumin as a standard.3. Results
3.1. Gulonolactone treatment causes a transient ER dilation
in mice
Mice were treated with a non-lethal single intraperitoneal
dose of gulonolactone (0.04, 0.4, 4 or 40 mmol/kg body
weight) and sacriﬁced 0.5 or 24 h after the treatment. To assess
the eﬃcacy of the gulonolactone treatment, ascorbate and
hydrogen peroxide levels were measured in liver homogenates.
Only moderate increase in ascorbate and hydrogen peroxide
concentrations was observed up to 4 mmol/kg body weight
gulonolactone doses at 0.5 h (data not shown). Gulonolactone
(40 mmol/kg body weight) caused a statistically signiﬁcant in-
crease in both ascorbate and hydrogen peroxide concentra-
tions (Fig. 1A and B); therefore, this dosage was applied in
the further experiments. The elevated hepatic concentrations
returned to (Fig. 1A) or below (Fig. 1B) the control level after
24 h. Gulonolactone treatment at high concentration resulted
in the swelling of the liver at 30 min with the signiﬁcant in-
crease in liver weight, which completely disappeared within
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Fig. 1. Gulonolactone treatment stimulates gulonolactone oxidase activity and provokes hepatic swelling in mice. Liver homogenates were prepared
from control mice and mice treated with a single intraperitoneal dose of gulonolactone (40 mmol/kg body weight) 30 min or 24 h before sacriﬁcing.
The two products of gulonolactone oxidase, ascorbate (panel A) and hydrogen peroxide (panel B) were measured in the homogenates. Liver weights
(panel C) were also determined. Results are expressed as means ± S.E.M., n = 4–8, *P < 0.05.
E´. Margittai et al. / FEBS Letters 582 (2008) 4131–4136 413324 h (Fig. 1C). Electron microscopy revealed a dramatic dila-
tion of the ER cisternae in the liver, while mitochondrial and
nuclear structures looked intact in the 30-min samples. The
alteration was completely reversible; the 24-h samples were
indistinguishable from the controls (Fig. 2).
To clarify the role of hydrogen peroxide produced by gulon-
olactone oxidase in the observed alterations, the experiment
was also done in guinea pigs. This species lacks gulonolactone
oxidase activity due to multiple mutations in its gene [19].
Gulonolactone treatment resulted in a slight hepatic swelling
(presumably due to osmotic eﬀects), but morphological
changes were completely absent (data not shown).
3.2. Gulonolactone treatment causes a minor change in the
glutathione redox buﬀer of the ER
Previous data obtained in microsomal experiments and in
isolated murine hepatocytes indicated that gulonolactone-
dependent ascorbate (and hydrogen peroxide) formation was
accompanied with a preferential intraluminal oxidation of glu-
tathione [9,10]. Therefore, reduced GSH and total glutathione
contents were measured in the liver homogenates and micro-
somal fractions. Minor (non-signiﬁcant) decrease in GSH
was observed together with a moderate elevation of total glu-
tathione in microsomal fractions from gulonolactone-treatedFig. 2. Electron microscopy of liver reveals dramatic dilatation of ER cis
cytoplasm of liver cells appears to be normal (panel A). After gulonolacton
numerous small vesicles covered with ribosomes while mitochondria and nu
changes in ER are completely recovered 24 h after treatment (panel C) (ER,mice (Table 1). In agreement with the previous results, the
microsomal ratio of reduced/total glutathione signiﬁcantly de-
creased upon the treatment. In liver homogenates, both GSH
and total glutathione levels were slightly higher in gulonolac-
tone-treated mice. All diﬀerences were present only in the
0.5-h samples (Table 1).
The elevation of intravesicular glutathione content in the
microsomes prepared from gulonolactone-treated mice could
be explained by an increased uptake through a speciﬁc trans-
porter. Therefore, GSH transport across the microsomal mem-
brane was studied directly by the rapid ﬁltration method.
These measurements did not show any increase in the GSH up-
take in microsomes from gulonolactone-treated mice (data not
shown) suggesting that the stimulation of GSH transport is not
responsible for the phenomenon.
3.3. Gulonolactone treatment does not provoke ER stress
Redox imbalance in the ER is often associated with the
appearance of the signs of ER stress and the consecutive apop-
tosis [7]. Therefore, the expression of ER chaperones (GRP78,
GRP94), foldases (PDI, ERp72) and proapoptotic transcrip-
tion factor (GADD153) as well as the phosphorylation of
eIF2a and the proteolytic activation of procaspase-12 were
investigated by Western blot analysis. In addition, the redoxternae in gulonolactone-treated mice. In control, untreated samples
e treatment for 30-min the ER cisterns become dilated and they form
clear structures remain intact (panel B). These drastic morphological
endoplasmic reticulum; M, mitochondria. Bar = 1 lm).
Table 2
Eﬀect of gulonolactone treatment on the activity and latency of intraluminal enzymes of the ER. UDP-glucuronosyltransferase and mannose-6-
phosphatase activities were measured in native and permeabilized microsomal vesicles prepared from the livers of control and gulonolactone-treated
mice. Results are expressed as means ± S.E.M., n = 4–8.
Native Permeabilized 100 · native/permeabilized
Activity (nmol/min/mg protein)
UDP-glucuronosyltransferase
Control 2.58 ± 0.48 28.11 ± 2.07 9.17 ± 0.77
GL-treated 3.75 ± 0.67 26.93 ± 1.88 13.92 ± 2.86
Mannose-6-phosphatase
Control 0.78 ± 0.03 12.28 ± 0.88 6.32 ± 0.27
GL-treated 0.91 ± 0.06* 12.03 ± 0.67 7.60 ± 0.51*
*P < 0.05 vs control.
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Fig. 3. Eﬀect of gulonolactone treatment on sucrose eﬄux from
murine liver microsomal vesicles. Microsomes (15 mg of protein/ml)
were pre-equilibrated with 1 mM sucrose plus [U14C]sucrose at 22 C
for 2 h, then 100-fold diluted to initiate the eﬄux. At the indicated time
points, samples were rapidly ﬁltered and washed on a cellulose acetate/
nitrate ﬁlter membrane. The radioactivity associated with microsomes
retained by ﬁlters was measured by liquid scintillation counting.
Gulonolactone (10 mM) was added to the pretreated microsomes
5 min before zero time. A representative trace out of three is shown.
Table 1
Eﬀect of gulonolactone treatment on hepatic glutathione levels. Glutathione (reduced and total) levels were measured in homogenates and
microsomal fractions prepared from the livers of control mice and mice treated with a single intraperitoneal dose of gulonolactone (40 mmol/kg body
weight) 30 min before sacriﬁcing. GSH/total glutathione ratios were calculated separately for each sample. Results are expressed as means ± S.E.M.,
n = 4–8.
GSH Total glutathione GSH/total ratio
(nmol/mg protein)
Microsomal fraction Control 0.92 ± 0.15 1.48 ± 0.33 0.62 ± 0.05
GL-treated 0.86 ± 0.21 1.76 ± 0.24 0.49 ± 0.05*
Crude liver homogenate Control 43 ± 9 47 ± 8 0.91 ± 0.11
GL-treated 48 ± 14 55 ± 13 0.87 ± 0.15
*P < 0.05.
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also tested by AMS staining. No diﬀerences were observed be-
tween the livers from control and gulonolactone treated ani-
mals with respect to the above mentioned proteins (data not
shown).
3.4. Gulonolactone treatment increases the permeability of the
ER membrane
The morphological changes and the absence of the luminal
GSH depletion upon gulonolactone treatment suggested that
the membrane barrier of the ER was compromised. To verify
this assumption, permeability of microsomal membrane was
checked by measuring the activity of enzymes with intralumi-
nal active site and by detecting the membrane permeation of
various osmolytes.
Gulonolactone treatment caused a signiﬁcant increase in the
activity of mannose-6-phosphatase and a non-signiﬁcant eleva-
tion of UDP-glucuronosyltransferase activity measured in na-
tive microsomal vesicles (Table 2). The activity of these
enzymes is highly latent in native ER-derived microsomal ves-
icles and their latency can be diminished by membrane disrupt-
ing agents.
Osmotically induced vesicle shrinkage visualized by light
scattering technique was greatly reduced in microsomes from
gulonolactone-treated mice, while the concomitant swelling
phase was more rapid. The addition of the poorly permeant su-
crose or citrate resulted in less expressed vesicular shrinking
and in a faster recovery of the original volume (Table 2). Sim-
ilarly increased permeability was detected when the control
microsomes were pretreated with gulonolactone (10 mM,
5 min) in vitro (data not shown).
The increased permeation of sucrose in gulonolactone-pre-
treated microsomes was further validated by direct transport
measurements using the rapid ﬁltration method. The addition
Table 3
Eﬀect of gulonolactone treatment on the permeability of microsomal
membrane. Microsomal vesicles were prepared from control mice and
mice treated with a single intraperitoneal dose of gulonolactone
(40 mmol/kg body weight) 30 min before sacriﬁcing. Membrane
permeability was assessed by light scattering technique using citrate
or sucrose (40 mM ﬁnal concentration) as osmolytes. The initial peak
upon the addition of osmolytes and the slope of the consecutive
gradual decrease in light scattering were measured and used as
indicators of the vesicular membrane permeability. Results are
expressed as means ± S.E.M., n = 4–8.
Osmolyte Treatment Peak height (AU) Half-time of
recovery (min)
Citrate Control 41.50 ± 1.32 3.19 ± 0.47
GL-treated 31.75 ± 3.64* 2.35 ± 0.26
Sucrose Control 22.00 ± 2.34 1.57 ± 0.48
GL-treated 18.20 ± 3.43 0.88 ± 0.13*
*P < 0.05.
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sucrose-preloaded microsomal vesicles (Fig. 3 and Table 3).4. Discussion
The present ﬁndings demonstrate that intraluminal hydro-
gen peroxide generation in the ER – provoked by a stimulated
gulonolactone oxidase activity – results in a transitory perme-
ability change in the ER membrane. Previous in vitro studies
showed that the conversion of gulonolactone to ascorbate
causes GSH consumption in isolated murine hepatocytes and
this GSH consumption was shown to be preferentially intralu-
minal in glutathione-loaded hepatic microsomal vesicles. The
role of hydrogen peroxide generated during ascorbate synthe-
sis in the depletion of GSH was also veriﬁed. The major ﬁnd-
ing of the in vitro studies is conﬁrmed by the present in vivo
data; gulonolactone-dependent hydrogen peroxide formation
is accompanied with a decreased GSH/total glutathione ratio
preferentially in the ER lumen. In addition, this new experi-
mental model revealed also the elevation of the hepatic total
glutathione level after gulonolactone treatment. This eﬀect is
presumably due to an increased synthesis; c-glutamylcysteinyl
synthetase (the key enzyme of glutathione synthesis) is known
to be stimulated by increasing GSSG concentration [20]. More
importantly, luminal GSH oxidation resulted in the increase of
total microsomal glutathione content rather than in the deple-
tion of the luminal GSH pool. This observation indicates a fast
replenishment of luminal GSH from the cytosol, either by the
activation of a speciﬁc GSH uptake transport mechanism or
by an increase in the non-speciﬁc permeability of the ER mem-
brane. Our results favor the latter option: microsomal vesicles
prepared from gulonolactone-treated mice show an increased
permeability to a variety of low molecular weight compounds.
This permeability transition can also be modeled by gulonolac-
tone addition to microsomal incubations.
ROS (presumably hydrogen peroxide) is an undesired side-
product of disulﬁde bond formation in the ER lumen. Its gen-
eration can lead to redox imbalance and hence can contribute
to the ER stress caused by the overproduction of secretory
proteins [6]. Although hydrogen peroxide is able to cross bio-
logical membranes, e.g. by the mediation of aquaporins
[21,22], membranes still represent an obstacle for it [22,23].
Consequently, elevated hydrogen peroxide concentrationscan be expected in the ER during extensive disulﬁde bond syn-
thesis. However, direct demonstration of luminal hydrogen
peroxide accumulation is still missing. It is particularly inter-
esting, since powerful hydrogen peroxide-metabolizing system
in the lumen has not been demonstrated. The ﬁndings reported
here might represent an explanation for the virtual inconsis-
tency; the increased permeability of the ER membrane caused
by luminally accumulating hydrogen peroxide would allow the
escape of oxidizing agents from the lumen and the inﬂux of
reducing equivalents (e.g. GSH) from the cytosol. This phe-
nomenon can be regarded as a novel protective response to
the luminal ROS overproduction. The ER lumen characterized
by a limited antioxidant capacity needs to seek help from the
cytosol, which is abundant in antioxidants. The transient alter-
ations observed in our experiments are indicative of the eﬀec-
tiveness of this mechanism to recover the normal redox
conditions and functionality of the challenged ER. It is possi-
ble, however, that a sustained increase in the permeability of
the ER membrane would trigger additional responses, e.g. un-
folded protein response, permeability changes in the plasma
membrane or even cell death.
Nevertheless, an important question emerges: what is the
structural basis of the altered membrane permeability? Several
ER channels – e.g. IP3R [24–26], and ryanodine receptor cal-
cium channels [27,28] – are sensitive to redox eﬀects, and their
open probability can be governed by oxidoreductions. More-
over, some channels (e.g. translocon peptide channel and ryan-
odine receptor calcium channel) can mediate the
transmembrane ﬂux of small molecules. The ‘‘general’’ perme-
ability of the ER membrane (i.e. permeability that cannot be
attributed to identiﬁed pores/channels) can also be inﬂuenced
by redox alterations. Further investigation is needed to explore
the mechanisms underlying the observed permeability transi-
tion in the ER membrane.
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